Sam Smith on the Association Between Adherence and Menopausal Symptoms

January 24, 2017

Video

Sam Smith, PhD, discusses the relationship between menopausal symptoms and non-adherence in patients receiving tamoxifen.

Sam Smith, PhD, from University of Leeds, discusses the association between menopausal symptoms and adherence for patients with breast cancer taking tamoxifen.

This trial matched a patient’s adherence to the menopausal symptoms they experienced. Symptoms measured were headaches, nausea and vomiting, gynecologic issues, and hot flashes. Although no association was found between gynecologic symptoms or hot flashes and nonadherence, researchers did find that patients who experienced nausea and vomiting or headaches were less likely to adhere to their medication.

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!

Related Content

Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC

June 30th 2025

Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer

October 2nd 2023

Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Anatomical image of a person with a breast tumor

T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

Tim Cortese

June 11th 2025

Article

T-DXd led to an ORR of 59.4% vs 33.9% with chemo, regardless of biomarker status, in HR+, HER2-low metastatic breast cancer, per DESTINY-Breast06.

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer

January 16th 2023

Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.